SKSabrina Klopsch

Sabrina Klopsch

*This is an algorithmically generated author record based on publicly available information.

Sabrina Klopsch has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Phenylalanine Modification in Plasma-Driven Biocatalysis Revealed by Solvent Accessibility and Reactive Dynamics in Combination with Protein Mass Spectrometry

    by Hanna-Friederike Poggemann, Sabrina Klopsch, Simon Homann, Tim Dirks, Sina Schäkermann, Julia E. Bandow, Timo Jacob, Christoph Jung

    Biocatalysis is an emerging field that provides an environmentally friendly alternative to conventional catalysis but still faces some challenges. One of the major difficulties for biocatalysts that require reactive species like H2O2 as cosubstrates lies in the concentration of these reactive species. On the one hand, they are used as reactants; on the other hand, they inactivate the enzymes at high concentrations. When utilizing nonthermal plasma to deliver H2O2 for biocatalysis, it is essential to understand the potential interactions between plasma-generated species (PGS) and enzymes. This is particularly important because, alongside H2O2, other reactive species such as hydroxyl radicals, atomic oxygen, superoxide, and nitric oxide are also produced. The investigation of the localized reactivity of the solvent accessible surface area (SASA) of an enzyme, with certain species, is an important tool for predicting these interactions. In combination with reactive molecular dynamics (MD) simulations, this enabled us to identify amino acid residues that are likely targets for modifications by the PGS. A subset of the theoretical predictions made in the present study was confirmed experimentally by mass spectrometry, leading to the discovery of plasma-mediated phenylalanine modifications. This result underlines the utility of the SASA and MD-based screening approach to direct time-consuming experiments and assist their interpretation.


  • Open Access

    Plasma-driven biocatalysis using the cytochrome P450 enzyme CYP152 BSβ

    by Tim Dirks, Sabrina Klopsch, Davina Stoesser, Sophie Desdemona Trenkle, Abdulkadir Yayci, Steffen Schüttler, Judith Golda, Julia Elisabeth Bandow

    Plasma-driven biocatalysis utilizes in situ H 2 O 2 production by atmospheric pressure plasmas to drive H 2 O 2 -dependent enzymatic reactions. Having previously established plasma-driven biocatalysis using recombinant unspecific peroxygenase from Agrocybe aegerita (r Aae UPO) to produce ( R )-1-phenylethanol from ethylbenzene (ETBE), we here employed CYP152 from Bacillus subtilis (CYP152 BSβ ). CYP152 BSβ naturally hydroxylates medium and long-chain carboxylic acids, and, with short-chain carboxylic acids as decoy molecules, also converts non-natural substrates such as ETBE. To produce active CYP152 BSβ overexpression and heme loading were optimized. The conversion of the non-natural substrates guaiacol and ABTS with heptanoic acid as decoy molecule and H 2 O 2 from stock solution yielded 18.28 and 21.13 nmol product min -1 , respectively. These reactions also served to assess compatibility of CYP152 BSβ with plasma-driven biocatalysis regarding temperature and H 2 O 2 operating windows. To establish CYP152 BSβ -based plasma-driven biocatalysis, immobilized enzyme in a rotating bed reactor (5 ml reaction volume) was then supplied with H 2 O 2 from a capillary plasma jet operated with 1280 ppm H 2 O in helium. After a 120 min run time a turnover number (TON) of 18.82 mol ( R )-1-PhOl was reached. We conclude that plasma-driven biocatalysis can be extended to other H 2 O 2 -dependent enzymes. Future efforts will be directed at increasing the TON and product range.

  • Open Access

    Immobilization protects enzymes from plasma-mediated inactivation

    by Tim Dirks, Abdulkadir Yayci, Sabrina Klopsch, Marco Krewing, Wuyuan Zhang, Frank Hollmann, Julia E. Bandow

    Non-thermal plasmas are used in various applications to inactivate biological agents or biomolecules. A complex cocktail of reactive species, (vacuum) UV radiation and in some cases exposure to an electric field together cause the detrimental effects. In contrast to this disruptive property of technical plasmas, we have shown previously that it is possible to use non-thermal plasma-generated species such as H 2 O 2 as cosubstrates in biocatalytic reactions. One of the main limitations in plasma-driven biocatalysis is the relatively short enzyme lifetime under plasma-operating conditions. This challenge could be overcome by immobilizing the enzymes on inert carrier materials. Here, we tested whether immobilization is suited to protect proteins from inactivation by plasma. To this end, using a dielectric barrier discharge device (PlasmaDerm), plasma stability was tested for five enzymes immobilized on ten different carrier materials. A comparative analysis of the treatment times needed to reduce enzyme activity of immobilized and free enzyme by 30% showed a maximum increase by a factor of 44. Covalent immobilization on a partly hydrophobic carrier surface proved most effective. We conclude from the study, that immobilization universally protects enzymes under plasma-operating conditions, paving the way for new emerging applications.